Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China flag China · Delayed Price · Currency is CNY
12.02
-0.11 (-0.91%)
Nov 17, 2026, 3:00 PM CST

SHA:600161 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,9011,9912,6864,5553,7134,330
Cash & Short-Term Investments
1,9011,9912,6864,5553,7134,330
Cash Growth
0.20%-25.86%-41.04%22.68%-14.25%147.68%
Accounts Receivable
2,2262,2021,12194.131,1731,027
Other Receivables
4.987.613.4539.0828.3622.27
Receivables
2,2312,2091,134133.211,2011,050
Inventory
4,2564,0223,8692,8442,3322,144
Other Current Assets
113.4949.5833.436.5324.8722.27
Total Current Assets
8,5028,2727,7227,5697,2717,546
Property, Plant & Equipment
5,8355,9065,8484,8864,0552,631
Long-Term Investments
133.85143.2143.2146.06146.06146.06
Goodwill
572.15572.15572.15173.92173.92127.93
Other Intangible Assets
925.41880.47917.05686.88441.63370.99
Long-Term Deferred Tax Assets
62.0556.4341.7746.7460.6367.01
Long-Term Deferred Charges
661.96655.09507.82470.26552.69362.46
Other Long-Term Assets
113.5797.76117.66208.66228.88326.85
Total Assets
16,80616,58315,87014,18812,92911,578

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
81.1581.3681.45179.169.3973.7
Accrued Expenses
234.32153.87170.46168.69163.21150.02
Short-Term Debt
0.5677.12----
Current Portion of Long-Term Debt
----112.99108.15
Current Portion of Leases
15.915.698.9617.9510.8216.51
Current Income Taxes Payable
139.7879.51148.2161.8573.7944.86
Current Unearned Revenue
176.52177.89213.19357.26292.72215.31
Other Current Liabilities
398.34449.21498.07494.78434.44201.03
Total Current Liabilities
1,0471,0351,1201,2801,157809.58
Long-Term Debt
----253.75366.25
Long-Term Leases
62.7968.0144.8624.4225.6218.01
Long-Term Unearned Revenue
92.5498.66107.4499.56101.992.69
Long-Term Deferred Tax Liabilities
57.5864.2262.4428.8530.8720.14
Other Long-Term Liabilities
1.241.241.241.244.14.1
Total Liabilities
1,2611,2671,3361,4341,5741,311

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,9771,9771,9771,6481,6481,373
Additional Paid-In Capital
2,4632,4632,4632,7932,7933,067
Retained Earnings
7,4317,2956,6985,3824,3553,612
Comprehensive Income & Other
-0.1-0.1-0.1-0.1-0.1-0.1
Total Common Equity
11,87111,73511,1399,8238,7958,052
Minority Interest
3,6743,5813,3942,9322,5602,215
Shareholders' Equity
15,54515,31614,53312,75411,35610,267
Total Liabilities & Equity
16,80616,58315,87014,18812,92911,578

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
79.25160.8253.8242.37403.17508.92
Net Cash (Debt)
1,8221,8302,6324,5133,3103,821
Net Cash Growth
9.33%-30.46%-41.68%36.34%-13.38%303.40%
Net Cash Per Share
0.940.921.332.281.661.97
Filing Date Shares Outstanding
1,9771,9771,9771,9771,9771,977
Total Common Shares Outstanding
1,9771,9771,9771,9771,9771,977
Working Capital
7,4557,2386,6026,2906,1136,736
Book Value Per Share
6.005.935.634.974.454.07
Tangible Book Value
10,37410,2839,6508,9628,1807,553
Tangible Book Value Per Share
5.255.204.884.534.143.82
Buildings
-2,9632,7112,2411,957963.02
Machinery
-3,1222,7602,2181,9961,258
Construction In Progress
-2,1772,4782,0441,5321,623